AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30193001
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (0.8 mg)/vitamin B12 (0.4 mg)/vitamin B6 (40 mg)
Trial: 17645592
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (0.8 mg)/vitamin B12 (0.4 mg)
Trial: 17645592
Drug: Vitamin B6
RxNorm normalized name: vitamin B6
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B6 (40 mg) alone
Trial: 16030154
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE; 100 mg, i.m., weekly) + 125 microg levonorgestrel (LNG) daily, orally
Trial: 16030154
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE; 100 mg, i.m., weekly) + 125 microg LNG daily, orally + 0.5 mg dutasteride daily, orally
Trial: 16030154
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE; 100 mg, i.m., weekly) + 300 microg/kg acyline twice weekly, s.c.
Trial: 16030154
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE; 100 mg, i.m., weekly) + 125 microg LNG daily, orally + 300 microg/kg acyline twice weekly, s.c.
Trial: 12871685
Drug: L-NAME (1mg/Kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NAME (1mg/Kg bolus and 1mg/Kg/h continuous IV drip for 5h)
Trial: 10434810
Drug: Vecuronium 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.2 mg kg‐1
Trial: 6147155
Drug: Suxamethonium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suxamethonium 1.5 mg kg‐1 (preceded by gallamine 20 mg 2 min earlier)
Trial: 6147155
Drug: Vecuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.1 mg kg‐1 to 0.2 mg kg‐1
Trial: 10566566
Drug: Preprandial insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preprandial insulin lispro plus sulfonylurea (L + S)
Trial: 10566566
Drug: Bedtime neutral
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime neutral protamine Hagedorn (NPH) insulin plus sulfonylurea (N + S)
Trial: 10566566
Drug: Preprandial insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preprandial insulin lispro plus bedtime NPH insulin (L + N)
Trial: 8960576
Drug: Nitroglycerin administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin administration
Trial: 15646732
Drug: Metoprolol treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol treatment
Trial: 20031608
Drug: Verapamil treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil treatment
Trial: 29097388
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with thiazide diuretic and β-blocker
Trial: 24560012
Drug: Paclitaxel, carboplatin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel, carboplatin, and mapatumumab (10 mg/kg or 30 mg/kg)
Trial: 10601174
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (CrS) - 6 x (5 g Cr‐H(2)O + 5 g dextrose)/day for 5 days
Trial: 10601174
Drug: Placebo -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo - 6 x 5 g dextrose/day for 5 days
Trial: 8954023
Drug: MK-677 25
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-677 25 mg/day
Trial: 1752455
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg four times a day for 8 to 16 weeks
Trial: 1752455
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg twice a day
Trial: 7042087
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy or BCG immunotherapy
Trial: 31013455
Drug: Cannabis containing
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabis containing THC (Cann‐CBD; 8 mg THC)
Trial: 31013455
Drug: Cannabis containing
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabis containing THC with CBD (Cann+CBD; 8 mg THC + 10 mg CBD)
Trial: 8672412
Drug: Soyabean-protein isolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soyabean-protein isolate (< 0.01 g phytic acid/kg)
Trial: 1458074
Drug: Danazol (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol (600 mg repeated after 12 hours)
Trial: 1424618
Drug: Mifepristone (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone (600 mg single dose)
Trial: 27149586
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy exercise program (3 months)
Trial: 16471090
Drug: Weekly cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly cisplatin (40 mg/m² per week for six cycles)
Trial: 16471090
Drug: Three-weekly cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Three-weekly cisplatin (75 mg/m² on days 1, 22, 43, and 64)
Trial: 10669911
Drug: 1,000 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg/day of citicoline
Trial: 8758141
Drug: Chloroquine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (25 mg base/kg over the first 3 days)
Trial: 8758141
Drug: Tetracycline (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline (4 mg/kg four times daily)
Trial: 2435150
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy regimen (ABV/ADV) including doxorubicin, vinblastine, bleomycin/actinomycin D, vincristine, dacarbazine.
Trial: 2435150
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment arms (recombinant alpha interferon and ABV/ADV)
Trial: 30354950
Drug: Pantoprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole (40 mg intravenous daily)
Trial: 25611729
Drug: Standard ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Standard ribavirin dosing (group 1)
Trial: 25611729
Drug: Low and
RxNorm normalized name: ZINC OXIDE 88 mg in 1 mL TOPICAL LOTION [Ciele Glow and Protect]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low and escalating ribavirin dosing (group 2)
Trial: 10443129
Drug: Topical levobunolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical levobunolol
Trial: 7719088
Drug: Kanggan Zhibao
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Kanggan Zhibao (KGZB) oral liquor
Trial: 5440736
Drug: 1·2 mega‐units
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1·2 mega‐units of aqueous procaine penicillin plus 1·0 g of probenecid given orally immediately prior to injection
Trial: 26735225
Drug: Chloroquine 150
RxNorm normalized name: chloroquine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine 150 mg once daily for 8 weeks
Trial: 26735225
Drug: Placebo once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo once daily for 8 weeks
Trial: 18071720
Drug: Capecitabine and
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine and irinotecan with concurrent radiation (50.4 Gy)
Trial: 18071720
Drug: Capecitabine, irinotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine, irinotecan and cetuximab with concurrent radiation (50.4 Gy)
Trial: 10562782
Drug: melatonin 5
RxNorm normalized name: melatonin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: melatonin 5 mg
Trial: 20523253
Drug: midazolam 15
RxNorm normalized name: midazolam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: midazolam 15 mg
Trial: 28494455
Drug: Testing for
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testing for specific IgE antibodies against Bet v 6
Trial: 26488737
Drug: Aloe vera-olive
RxNorm normalized name: ALOE VERA
DrugBank: Aloe vera leaf (DB13906)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe vera-olive oil (AVO) cream
Trial: 17263742
Drug: i.v. ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. ketamine (0.5 mg/kg) (Group II)
Trial: 17263742
Drug: peritonsillar infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: peritonsillar infiltration of ketamine (0.5 mg/kg) (Group III)
Trial: 12189745
Drug: Tamsulosin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.4 mg once daily for 52 weeks)
Trial: 12189745
Drug: Tamsulosin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin + Serenoa repens (160 mg twice daily for 52 weeks)
Trial: 2786422
Drug: Ketanserin (0.05,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (0.05, 1 or 2 mg kg‐1 h‐1)
Trial: 2786422
Drug: Ketanserin (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (low and high doses)
Trial: 2786422
Drug: Ketanserin (medium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (medium dose)
Trial: 7208541
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg pivampicillin twice daily
Trial: 7372355
Drug: 350 mg
RxNorm normalized name: hemin 350 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 mg pivampicillin three times daily
Trial: 17618948
Drug: Amino acids
RxNorm normalized name: Amino acids
DrugBank: Amino acids (DB09393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acids (Travasol 10% at 0.02 mL.kg(‐1).min(‐1))
Trial: 17618948
Drug: Amino acids
RxNorm normalized name: Amino acids
DrugBank: Amino acids (DB09393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acids (Travasol 10% at 0.02 mL.kg(‐1).min(‐1)) with glucose (4 mg.kg(‐1).min(‐1))
Trial: 10202827
Drug: Ritonavir 400
RxNorm normalized name: lopinavir-ritonavir 400 mg-100 mg/5 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir 400 mg and saquinavir 400 mg twice daily
Trial: 10202827
Drug: Ritonavir 600
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir 600 mg and saquinavir 400 mg twice daily
Trial: 10202827
Drug: Ritonavir 400
RxNorm normalized name: lopinavir-ritonavir 400 mg-100 mg/5 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir 400 mg and saquinavir 400 mg three times daily
Trial: 10202827
Drug: Ritonavir 600
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir 600 mg and saquinavir 600 mg twice daily
Trial: 10202827
Drug: Ritonavir‐saquinavir 600‐600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir‐saquinavir 600‐600 mg twice daily
Trial: 8848902
Drug: Intravenous ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ketoprofen 100 mg i.v. 2 min prior to induction of anaesthesia and an additional 100 mg infused in 60 min
Trial: 10456820
Drug: Intravenous ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ketoprofen
Trial: 2286466
Drug: Fosfomycin trometamol
RxNorm normalized name: trometamol
DrugBank: Tromethamine (DB03754)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfomycin trometamol (3 g) single dose
Trial: 2286466
Drug: Norfloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin (400 mg twice daily for three days)
Trial: 6779682
Drug: 24‐h continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24‐h continuous oxygen therapy
Trial: 6779682
Drug: 12‐h nocturnal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12‐h nocturnal oxygen therapy
Trial: 23652888
Drug: Daily shaving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily shaving with advanced products
Trial: 23652888
Drug: Daily shaving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily shaving with standard products
Trial: 21388554
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (3 times per week for 24 sessions over 8 weeks)
Trial: 21388554
Drug: Waitlist group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waitlist group (no acupuncture treatment for 8 weeks)
Trial: 15519660
Drug: Alamifovir at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alamifovir at a total daily dose ranging from 2.5 to 20mg
Trial: 11543734
Drug: Pindolol augmentation
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pindolol augmentation
Trial: 9209187
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg Fe, 750 micrograms retinol, 250 micrograms folic acid, and 60 mg vitamin C per day
Trial: 9209187
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg Fe, 6000 micrograms retinol, 500 mg folic acid, and 60 mg vitamin C once a week
Trial: 9209187
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg Fe and the same amount of the other three micronutrients as the second group once a week
Trial: 3582475
Drug: Ranitidine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine alone (150 mg)
Trial: 3582475
Drug: Ranitidine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine with aluminum phosphate (11 g)
Trial: 26361281
Drug: Time-delayed MRI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time-delayed MRI with gadobenate dimeglumine (0.1-mmol/kg) administered immediately, followed by 2 axial T1-weighted sequences after 5-minute intervals (final image acquisition at 15 minutes).
Trial: 26523330
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg triptorelin
Trial: 11836309
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg leuprorelin
Trial: 7577200
Drug: Short, pulse-intensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short, pulse-intensive (single-dose) treatment regimens
Trial: 23974823
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment regimens (implied control)
Trial: 7151268
Drug: 0.01 mg
RxNorm normalized name: urea 0.01 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 mg LT
Trial: 7151268
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg LT
Trial: 25179689
Drug: APF530 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APF530 250 mg
Trial: 19436223
Drug: CE cream
RxNorm normalized name: NAIR FACE CREAM,TOP
DrugBank: Cholesteryl Linoleate (DB02092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CE cream 0.3 mg daily for 12 weeks
Trial: 19436223
Drug: CE cream
RxNorm normalized name: NAIR FACE CREAM,TOP
DrugBank: Cholesteryl Linoleate (DB02092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CE cream 0.3 mg twice weekly for 12 weeks
Trial: 19436223
Drug: CE cream
RxNorm normalized name: NAIR FACE CREAM,TOP
DrugBank: Cholesteryl Linoleate (DB02092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CE cream 0.3 mg daily and twice weekly
Trial: 12846752
Drug: rhEPO in
RxNorm normalized name: rhTPO
DrugBank: Recombinant Human Thrombopoietin (DB16364)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhEPO in combination with intravenous iron
Trial: 10714731
Drug: 5 mg/d
RxNorm normalized name: Arixtra 5 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/d of alendronate sodium
Trial: 10714731
Drug: 60 or
RxNorm normalized name: QM-260 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 or 120 mg/d of raloxifene hydrochloride
Trial: 9678115
Drug: Monophasic oral
RxNorm normalized name: hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Urelle]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monophasic oral contraceptive containing 75 micrograms gestodene and 20 micrograms ethinylestradiol
Trial: 21120497
Drug: Active laser
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active laser therapy with a dosage of 1.2 J/per painful point
Trial: 21120497
Drug: Active laser
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active laser therapy with a dosage of 0.6 J/per painful point
Trial: 20590735
Drug: glimepiride 8
RxNorm normalized name: glimepiride 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: glimepiride 8 mg
Trial: 3631471
Drug: morphine 5
RxNorm normalized name: ethylmorphine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: morphine 5 mg
Trial: 16119597
Drug: morphine 1
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: morphine 1 mg with methylprednisolone 40 mg
Trial: 10192751
Drug: Topical heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical heparin (1000 IU x g(‐1), applied three times daily for a maximum of 7 days)
Trial: 10192751
Drug: Topical heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical heparin and Placebo
Trial: 7587700
Drug: BCG instillation
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG instillation therapy
Trial: 7587700
Drug: TTP instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTP instillation therapy
Trial: 7587700
Drug: MMC instillation
RxNorm normalized name: MMC
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MMC instillation therapy
Trial: 7587700
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no instillation therapy)
Trial: 2271367
Drug: Clomipramine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (75 mg for extensive metabolisers, 50 mg for poor metabolisers)
Trial: 2271367
Drug: Desipramine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramine (200 mg for extensive metabolisers, 50 mg for poor metabolisers)
Trial: 231736
Drug: metoclopramide syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoclopramide syrup
Trial: 231736
Drug: prochlorperazine tablets
RxNorm normalized name: Prochlorperazine
DrugBank: Prochlorperazine (DB00433)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: prochlorperazine tablets
Trial: 31564689
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy using purified cedar allergen
Trial: 29692285
Drug: Metacognitive Reflection
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metacognitive Reflection and Insight Therapy (MERIT), 40 sessions
Trial: 23312052
Drug: IPE 4
RxNorm normalized name: miconazole/cleanser 17 on wipe 4 % (200 mg)-2 % (9 gram) VAGINAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IPE 4 g/day
Trial: 23312052
Drug: IPE 2
RxNorm normalized name: miconazole/cleanser 17 on wipe 2 % (100 mg)-2 % VAGINAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IPE 2 g/day
Trial: 23040523
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist acyline
Trial: 19190344
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg supplemental vitamin E (alpha‐tocopherol) per day
Trial: 16723156
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of intravenous methylprednisolone
Trial: 11115208
Drug: Guideline-concordant antidepressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline-concordant antidepressant medication or specialty counseling
Trial: 1528609
Drug: Low-dose antigen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose antigen injection
Trial: 3877291
Drug: Pethidine 50‐75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine 50‐75 mg intramuscularly and atropine 0.6 mg intramuscularly
Trial: 31862740
Drug: Fascia iliaca
RxNorm normalized name: OCTINOXATE .012 mL in 6 mL / OCTISALATE .12 mL in 6 mL TOPICAL CREAM [RIMMEL LONDON MOISTURE RENEW LIPGLOSS - FUSCIA THERAPHY (345)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fascia iliaca compartment block (FICB) administered by trained paramedics